These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
302 related articles for article (PubMed ID: 30980544)
1. Red blood cell alloantibodies are associated with increased alloimmunization against human leukocyte antigens. Belizaire R; Mack J; Kadauke S; Kim Y; Saidman S; Makar RS Transfusion; 2019 Jul; 59(7):2256-2263. PubMed ID: 30980544 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of HLA antibodies in transfused patients with and without red cell antibodies. Buetens O; Shirey RS; Goble-Lee M; Houp J; Zachary A; King KE; Ness PM Transfusion; 2006 May; 46(5):754-6. PubMed ID: 16686842 [TBL] [Abstract][Full Text] [Related]
3. Red cell alloimmunization in multitransfused HLA-typed patients. Brantley SG; Ramsey G Transfusion; 1988; 28(5):463-6. PubMed ID: 3420675 [TBL] [Abstract][Full Text] [Related]
4. HLA alloimmunization is associated with RBC antibodies in multiply transfused patients with sickle cell disease. McPherson ME; Anderson AR; Castillejo MI; Hillyer CD; Bray RA; Gebel HM; Josephson CD Pediatr Blood Cancer; 2010 Apr; 54(4):552-8. PubMed ID: 19890898 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and specificities of red blood cell alloantibodies in transfused Ugandans with different diseases. Natukunda B; Schonewille H; van de Watering L; Brand A Vox Sang; 2010 Feb; 98(2):167-71. PubMed ID: 19708889 [TBL] [Abstract][Full Text] [Related]
6. In utero exposure to alloantigens primes alloimmunization to platelet transfusion in mice. Poston JN; Jash A; Hannan LM; Hay AM; Usaneerungrueng C; Howie HL; Kapp LM; Zimring JC Transfusion; 2021 Mar; 61(3):687-691. PubMed ID: 33336414 [TBL] [Abstract][Full Text] [Related]
7. Red blood cell transfusions are associated with HLA class I but not H-Y alloantibodies in children with sickle cell disease. Nickel RS; Hendrickson JE; Yee MM; Bray RA; Gebel HM; Kean LS; Miklos DB; Horan JT Br J Haematol; 2015 Jul; 170(2):247-56. PubMed ID: 25891976 [TBL] [Abstract][Full Text] [Related]
8. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Sanz C; Nomdedeu M; Belkaid M; Martinez I; Nomdedeu B; Pereira A Transfusion; 2013 Apr; 53(4):710-5. PubMed ID: 22845746 [TBL] [Abstract][Full Text] [Related]
9. HLA Class II regulation of immune response in sickle cell disease patients: Susceptibility to red blood cell alloimmunization (systematic review and meta-analysis). Wong K; Lai WK; Jackson DE Vox Sang; 2022 Nov; 117(11):1251-1261. PubMed ID: 36102140 [TBL] [Abstract][Full Text] [Related]
10. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. Wong M; Narra R; Selim M; Zimmerman MA; Kim J; Padmanabhan A; Hong JC J Surg Res; 2020 Nov; 255():99-105. PubMed ID: 32543385 [TBL] [Abstract][Full Text] [Related]
11. Granulocyte-reactive antibodies are associated with red blood cell alloimmunization. Schönbacher M; Heinzl MW; Dauber EM; Mayr WR; Panzer S; Körmöczi GF Vox Sang; 2014 Aug; 107(2):200-3. PubMed ID: 24712334 [TBL] [Abstract][Full Text] [Related]
12. Screening for new red blood cell alloantibodies after transfusion in patients with sickle cell disease. Rankin A; Darbari D; Campbell A; Webb J; Mo YD; Jacquot C; Delaney M; Luban NLC; Nickel RS Transfusion; 2021 Aug; 61(8):2255-2264. PubMed ID: 34002408 [TBL] [Abstract][Full Text] [Related]
13. Somatic mutations show no clear association with red blood cell or human leukocyte antigen alloimmunization in de novo or therapy-related myelodysplastic syndrome. Adkins BD; Mehta A; Selesky M; Vittitow S; Smolkin ME; Ratcliffe SJ; Luckey CJ Transfusion; 2022 Dec; 62(12):2470-2479. PubMed ID: 36278434 [TBL] [Abstract][Full Text] [Related]
14. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Natukunda B; Schonewille H; Ndugwa C; Brand A Transfusion; 2010 Jan; 50(1):20-5. PubMed ID: 19821949 [TBL] [Abstract][Full Text] [Related]
15. Non-transfusion dependent thalassemia is independently associated with higher alloimmunization risk than transfusion dependent thalassemia and would benefit the most from extended red cell antigen-matching. Ang AL; Lim CY; Ng WY; Lam JCM Transfusion; 2021 Sep; 61(9):2566-2577. PubMed ID: 34258773 [TBL] [Abstract][Full Text] [Related]
16. Analysis of platelet-reactive alloantibodies and evaluation of cross-match-compatible platelets for the management of patients with transfusion refractoriness. Wang J; Xia W; Deng J; Xu X; Shao Y; Ding H; Chen Y; Liu J; Chen D; Ye X; Santoso S Transfus Med; 2018 Feb; 28(1):40-46. PubMed ID: 28516675 [TBL] [Abstract][Full Text] [Related]
18. Immune erythrocyte antibodies in adult patients with sickle cell disease and blood donors in Lagos, Nigeria: a comparative study. Adewoyin AS; Daramola OA; Ogbenna AA; Adeyemo TA Immunohematology; 2021 Sep; 37(3):131-137. PubMed ID: 34591378 [TBL] [Abstract][Full Text] [Related]
19. Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north India. Thakral B; Saluja K; Sharma RR; Marwaha N Hematology; 2008 Oct; 13(5):313-8. PubMed ID: 18854096 [TBL] [Abstract][Full Text] [Related]
20. Red blood cell alloimmunization from an African perspective. Natukunda B; Brand A; Schonewille H Curr Opin Hematol; 2010 Nov; 17(6):565-70. PubMed ID: 20827185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]